4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
REgenerative Stem cell therapy for STroke in Europe (RESSTORE)
Date du début: 1 sept. 2015, Date de fin: 31 août 2020,
Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and cognitive impairments, and secondary health problems affecting not only patients but also their families. Building on emerging preclinical and pilot clinical evidences, RESSTORE will focus on the clinical assessment of regenerative cell therapy to improve stroke ...
Voir le projet
29
Participants partenaires
TERMINÉ
Patient Empowerment through Predictive PERsonalised decision support (PEPPER)
Date du début: 1 févr. 2016, Date de fin: 31 janv. 2019,
This proposal is for a personalised decision support system for chronic disease management that will make predictions based on real-time data in order to empower individuals to participate in the self-management of their disease. The design will involve users at every stage to ensure that the system meets patient needs and raises clinical outcomes by preventing adverse episodes and improving lifes ...
Voir le projet
7
Participants partenaires
TERMINÉ
Efficacy and safety of MRI-based thrombolysis in wake-up stroke: a randomised, double-blind, placebo-controlled trial (WAKE-UP)
Date du début: 1 déc. 2011, Date de fin: 30 nov. 2017,
WAKE-UP is an investigator-initiated, multicentre, randomised, double-blind, placebo-controlled trial designed to test efficacy and safety of MRI-based intravenous thrombolysis in patients with wake-up stroke. Every year 1.5 million patients suffer a stroke in the EU. Up to 20% of stroke patients wake up with stroke symptoms. Currently these patients are excluded from thrombolysis which is the onl ...
Voir le projet
13
Participants partenaires
TERMINÉ
The role of intestinal microflora in non-alcoholic fatty liver disease (NAFLD) (FLORINASH)
Date du début: 1 janv. 2010, Date de fin: 31 déc. 2014,
As worldwide metabolic disease pandemics rise relentlessly with their concomitant clinical complications such as non alcoholic fatty liver disease, FLORINASH proposes an innovative research concept to address the role of intestinal microfloral activity in the pathogenesis of NAFLD. Firstly, to discover novel metabolic markers for the differential diagnosis and prediction of patient risk. Secondly, ...
Voir le projet